# Generation of proliferative hESC-derived grape-clustered hepatocyte organoids with multipolar architecture as regenerative counterpart via synergy of YAP and IGF2 pathways

**Authors:** Haibin Wu, Shoupei Liu, Sen Chen, Changlu Qin, Wenjiao Yan, Xiangting Cao, Yongjian Zhou, Yuyou Duan

PMC · DOI: 10.1038/s41419-026-08635-y · Cell Death & Disease · 2026-03-26

## TL;DR

Scientists created liver-like organoids from human embryonic stem cells that can grow and function like real liver cells, offering a new tool for liver research and disease modeling.

## Contribution

A defined system to generate proliferative, grape-like hepatocyte organoids from hESCs using synergy of YAP and IGF2 pathways.

## Key findings

- G-heporgs exhibit mature hepatocyte markers, binucleation, and bile canaliculi resembling PHH-derived organoids.
- IGF2 and YAP signaling together enable stable propagation of G-heporgs for over 60 days.
- G-heporgs recapitulate hepatocyte polarity and bile canalicular networks, showing regenerative competence.

## Abstract

Primary human hepatocyte (PHH)-derived organoids form grape-like clusters with proliferative capacity, hepatocyte functionality, and multipolar polarity, serving as valuable models for liver biology and therapeutics. However, deriving comparable organoids from human embryonic stem cells (hESCs) remains difficult. Here, we established a defined system to differentiate hESC-derived hepatoblast organoids into hepatocyte organoids (heporgs) with two morphologies: spheroid-like (S-heporgs) and grape-like (G-heporgs). S-heporgs predominated but displayed senescence and apoptosis, generating an inflammatory niche that facilitated G-heporg emergence. G-heporgs exhibited mature hepatocyte markers, binucleation, proliferative activity, and multipolar structures with branched bile canaliculi, closely resembling PHH-derived organoids. Transcriptomic and functional analyses identified IGF2-driven PI3K-AKT activation as essential for G-heporg formation, while YAP signaling supported their long-term expansion. IGF2 supplementation combined with YAP agonist treatment enabled stable G-heporg propagation for over 60 days. These expandable G-heporgs demonstrated regenerative competence and faithfully recapitulated hepatocyte polarity and functional bile canalicular networks, as evidenced by ATP7B copper-dependent translocation and drug-induced cholestasis assays. Our findings establish hESC-derived G-heporgs as expandable, functional counterparts to PHH-derived organoids, providing a robust platform for studying hepatocyte polarity, metabolite trafficking, and liver disease modeling.

## Linked entities

- **Genes:** ATP7B (ATPase copper transporting beta) [NCBI Gene 540]

## Full-text entities

- **Genes:** STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, IGF2R (insulin like growth factor 2 receptor) [NCBI Gene 3482] {aka CD222, CI-M6PR, CIMPR, M6P-R, M6P/IGF2R, MPR 300}, CCL20 (C-C motif chemokine ligand 20) [NCBI Gene 6364] {aka CKb4, Exodus, LARC, MIP-3-alpha, MIP-3a, MIP3A}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], Egf (epidermal growth factor) [NCBI Gene 13645], CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, Osm (oncostatin M) [NCBI Gene 18413] {aka OncoM}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, GOLGA1 (golgin A1) [NCBI Gene 2800] {aka golgin-97}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, CYP1B1 (cytochrome P450 family 1 subfamily B member 1) [NCBI Gene 1545] {aka ASGD6, CP1B, CYPIB1, GLC3A, P4501B1}, ASGR1 (asialoglycoprotein receptor 1) [NCBI Gene 432] {aka ASGPR, ASGPR1, CLEC4H1, HL-1}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, ATP7B (ATPase copper transporting beta) [NCBI Gene 540] {aka PWD, WC1, WD, WND}, CCND2 (cyclin D2) [NCBI Gene 894] {aka KIAK0002, MPPH3}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, TBX3 (T-box transcription factor 3) [NCBI Gene 6926] {aka TBX3-ISO, UMS, XHL}, IGFBP1 (insulin like growth factor binding protein 1) [NCBI Gene 3484] {aka AFBP, IBP1, IGF-BP25, PP12, hIGFBP-1}, CYP2C9 (cytochrome P450 family 2 subfamily C member 9) [NCBI Gene 1559] {aka CPC9, CYP2C, CYP2C10, CYPIIC9, P450-2C9, P450IIC9}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}, CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, CCN1 (cellular communication network factor 1) [NCBI Gene 3491] {aka CYR61, GIG1, IBP-10, IGFBP-10, IGFBP10}, GSTP1 (glutathione S-transferase pi 1) [NCBI Gene 2950] {aka DFN7, FAEES3, GST3, GSTP, GSTP1-1, HEL-S-22}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, OSM (oncostatin M) [NCBI Gene 5008], GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, ABCC2 (ATP binding cassette subfamily C member 2) [NCBI Gene 1244] {aka ABC30, CMOAT, DJS, MRP2, cMRP}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916] {aka CD107a, LAMPA, LGP120}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, Il11 (interleukin 11) [NCBI Gene 16156] {aka IL-11}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MRAP (melanocortin 2 receptor accessory protein) [NCBI Gene 56246] {aka B27, C21orf61, FALP, GCCD2, MRAP1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, IL32 (interleukin 32) [NCBI Gene 9235] {aka IL-32alpha, IL-32beta, IL-32delta, IL-32gamma, NK4, TAIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tgfa (transforming growth factor alpha) [NCBI Gene 21802] {aka wa-1, wa1}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, ABCB11 (ATP binding cassette subfamily B member 11) [NCBI Gene 8647] {aka ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4}, FGF4 (fibroblast growth factor 4) [NCBI Gene 2249] {aka FGF-4, HBGF-4, HST, HST-1, HSTF-1, HSTF1}, IGFBP2 (insulin like growth factor binding protein 2) [NCBI Gene 3485] {aka IBP2, IGF-BP53}, Fgf4 (fibroblast growth factor 4) [NCBI Gene 14175] {aka Fgf-4, Fgf7a, Fgfk, HBGF-4, Hst1, Hstf-1}
- **Diseases:** liver injury (MESH:D017093), necrosis (MESH:D009336), Cholestasis (MESH:D002779), Wilson disease (MESH:D006527), liver disease (MESH:D008107), toxicity (MESH:D064420), inflammatory (MESH:D007249), G-heporgs (MESH:D004314), S (MESH:D018455), inherited disorders (MESH:D030342), BC dysfunction (MESH:D001649), heporgs (MESH:D054000), DILI (MESH:D056486), PHH (MESH:D015459), acute liver failure (MESH:D017114), cysts (MESH:D003560)
- **Chemicals:** colcemid (MESH:D003703), Ome (MESH:D009853), acetic acid (MESH:D019342), CO2 (MESH:D002245), BODIPY (MESH:C095489), Hematoxylin (MESH:D006416), FSK (MESH:D005576), LY294002 (MESH:C085911), PFA (MESH:C003043), Ver (MESH:D014700), S (MESH:D013455), eosin (MESH:D004801), DAPI (MESH:C007293), glutaraldehyde (MESH:D005976), Nicotinamide (MESH:D009536), Chlorpromazine (MESH:D002746), Copper (MESH:D003300), Verteporfin (MESH:D000077362), essential amino acids (MESH:D000601), Urea (MESH:D014508), Lipid (MESH:D008055), uranyl acetate (MESH:C005460), Dex (MESH:D003907), ICG (MESH:D007208), Cyclosporine A (MESH:D016572), ammonium chloride (MESH:D000643), Rho123 (MESH:D020112), BCA (MESH:C047117), osmium tetroxide (MESH:D009993), X-gal (MESH:C044888), 2-mercaptoethanol (MESH:D008623), CDF (MESH:C035000), cholesterol (MESH:D002784), luminal (MESH:D010634), DMEM (-), Linsitinib (MESH:C551528), CHIR99021 (MESH:C473711), Streptomycin (MESH:D013307), Y27632 (MESH:C108830), KCl (MESH:D011189), SB431542 (MESH:C459179), Rhodamine (MESH:D012235), PBS (MESH:D007854), bile acid (MESH:D001647), BCS (MESH:C028559), CuSO4 (MESH:D019327), ethanol (MESH:D000431), BODIPY 493/503 (MESH:C527198), DMSO (MESH:D004121), Triton X-100 (MESH:D017830), Penicillin (MESH:D010406), SA (MESH:D000077145), H&amp;E (MESH:D006371), fatty acid (MESH:D005227), methanol (MESH:D000432), Rif (MESH:D012293), dUTP (MESH:C027078), phalloidin (MESH:D010590)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** G-heporg — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_3572), Goligin-97 — Homo sapiens (Human), Ataxia telangiectasia syndrome, Finite cell line (CVCL_WX49), hESC — Homo sapiens (Human), Embryonic stem cell (CVCL_9771), hESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95), -heporgs — Homo sapiens (Human), Transformed cell line (CVCL_S956), H9 — Homo sapiens (Human), Sezary syndrome, Cancer cell line (CVCL_1240)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039810/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039810/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039810/full.md

---
Source: https://tomesphere.com/paper/PMC13039810